DNA Helix

Technologies we work with

Synpromics enables unprecedented control of gene expression through its ability to custom design synthetic cell-type, or condition, specific promoters. We achieve this by using proprietary technology and cutting edge techniques including sophisticated bioinformatics and screening approaches.

Cell and Gene Therapy

Solving the challenge of targeted expression and enabling the next generation of genetic therapeutics

Patentable synthetic promoters for cell & gene therapy, enable specificity, enhanced therapeutic efficacy & increased clinical safety.

Read more

Vector Bioprocessing

​Creating next generation viral vector production systems to deliver higher titres and enable industrial-scale manufacturing of gene therapy products

Developing constitutive & inducible promoters for the creation of retroviral, lentiviral & AAV vector stable producer cell lines.

Read more


Enhancing the manufacture of biologics using promoters tailored to specific producer cell lines and the recombinant protein of interest

Improved bioprocessing yields, enhanced expression & increased extracellular protein secretion, in mammalian, yeast or bacterial systems.

Read more